No results for ‘’
Transchem Ltd
₹178.75
(1.53%)
Mon, 25 May 2026, 01:48 pm
Health Technology
Pharmaceuticals: Other
24.5KTranschem Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 22.12 | 18.61 | 5.96 | 0 | 0 | 0 | 0 | 0 | 0 | 221.50 | 437.50 | 0 | 0 | 95.30 | 48.57 | 0.85 | 9.39 | 18.71 | 8.17 | 7.80 |
| Price to book ratio | 0.35 | 0.58 | 0.43 | 0.15 | 0.35 | 0.41 | 0.49 | 0.79 | 0.73 | 0.71 | 0.56 | 0.72 | 1.08 | 0.77 | 0.54 | 0.32 | 0.41 | 0.35 | 0.45 | 0.51 |
| Price to sales ratio | 0.26 | 0.37 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83.80 | 15.50 |
| Price to cash flow ratio | 5.02 | 0 | 1.54 | 0 | 0 | 0 | 15.74 | 14.73 | 35.84 | 19.18 | 15.82 | 33.51 | 0 | 2.57 | 0 | 0 | 1.23 | 18.71 | 0 | 1.13 |
| Enterprise value | 121.18M | 286.05M | 208.34M | 62.3M | 158.27M | 198.77M | -19.5M | 71.58M | 32.13M | 12.4M | -57.94M | -5.55M | 313.32M | 127.36M | 35.18M | 87.3M | -72.92M | -113.53M | 340.41M | -15.81M |
| Enterprise value to EBITDA ratio | 6.15 | 12.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 0.03 | 0.11 | 0 | 0 | 0 | 0.07 | 0.07 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on equity % | 0 | 3.19 | 7.29 | -2.25 | -4.23 | -6.23 | -7.94 | -3.32 | -2.08 | 0.31 | 0.12 | -0.57 | -3.18 | 0.82 | 1.10 | 48.44 | 4.44 | 1.87 | 5.94 | 6.74 |
Transchem Ltd Enterprise Value
The Transchem Ltd Enterprise Value is a key financial metric used by investors to evaluate Transchem Ltd's valuation, profitability, and overall financial performance. Tracking the Transchem Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Transchem Ltd (NSE: TRANSCHEM, BSE: 500422) is currently trading at ₹178.75, with a market capitalization of ₹2.15B. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Transchem Ltd Enterprise Value is essential for fundamental analysis.
Transchem Ltd Enterprise Value Current Value
The current Transchem Ltd Enterprise Value stands at -15.81M.
The Transchem Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Transchem Ltd Enterprise Value Historical Trend
The Transchem Ltd Enterprise Value has shown the following historical trend:
- 2024: -15.81M
- 2023: 340.41M
- 2022: -113.53M
- 2021: -72.92M
- 2020: 87.3M
The decline in Transchem Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Transchem Ltd Enterprise Value Indicates for Investors
The Transchem Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Transchem Ltd.
Transchem Ltd Enterprise Value Analysis Summary
The Transchem Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Transchem Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Transchem Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.